CYP2C19 genotype status and intragastric pH during dosing with lansoprazole or rabeprazole [PDF]
, 2000 Kyoichi Adachi +9 more
openalex +1 more source
Oral pharmacokinetics of omeprazole and lansoprazole after single and repeated doses as intact capsules or as suspensions in sodium bicarbonate [PDF]
, 2000 Sharma, Peyton, Spears, Raufman, Howden
openalex +1 more source
Relationship between metabolism type of Lansoprazole in Japanese and pharmacodynamics of Diazepam.
, 1997 Koichi Nakamura
openalex +2 more sources
Lack of a pharmacokinetic interaction between lansoprazole or pantoprazole and theophylline [PDF]
, 2000 Pan Pan +4 more
openalex +1 more source
Safety of lansoprazole in the treatment of GERD in children
, 2000 V. Tolia +5 more
openalex +2 more sources
Lansoprazole-alternative method of administration of granules
, 1995 John H. Cavanaugh +3 more
openalex +1 more source
The gastric H,K‐ATPase blocker lansoprazole is an inhibitor of chloride channels [PDF]
, 2000 Andreas Schmarda +11 more
openalex +1 more source
Stereoselective pharmacokinetics of lansoprazole in normal person.
, 1996 MAHIRO NAKANO
openalex +2 more sources
Initial potency of lansoprazole and omeprazole tablets on pentagastrin‐stimulated gastric acid secretion—a placebo‐controlled study in healthy volunteers [PDF]
, 2000 Martín Müller +4 more
openalex +1 more source